AI Won’t Replace Radiologists Until 2040—Here’s the Math

A hospital CEO said AI could already replace “a great deal” of radiologists. Another called it “actually better than human beings.” Dr. A says both statements ignore the same inconvenient number: the false negative rate.In this episode, Dr. A breaks down the five hurdles that stand between today’s AI imaging tools and an actual radiologist replacement: radiologists trusting the technology enough to sign off on it, clinicians trusting an AI read without a second opinion, patients accepting an AI diagnosis, radiologists’ own resistance to being replaced, and the biggest fight of all: who takes on the liability when an AI misses a cancer. Running the clock on each hurdle, he lands on a prediction: real replacement doesn’t begin before January 2040.The claims are premature, they’re profitable for the hospitals making them, and none of the executives making them are radiologists.We Also Cover● For patients: An AI “read” on a mammogram or X-ray isn’t a diagnosis on its own, a radiologist’s second read is still the standard of care, and patients should ask whether a human physician reviewed their scan before acting on it.● For clinicians: The technology’s real bottleneck isn’t accuracy alone, it’s trust, liability, and regulation. Current AI tools are decision-support, not a replacement for radiologist interpretation, no matter what a hospital CEO claims publicly.●  System-level: No one has settled who’s liable when an AI misses a cancer, the software vendor, the hospital, or no one and that unresolved question, not the technology itself, is what’s actually slowing deployment.

The night before a man in his mid-forties was set for the cancer surgery that gave him his best shot at survival, his insurer called the treatment experimental and refused to pay. He was a father of three. He did not survive the fight that came next.In this episode, Dr. A lays out how insurers lean on algorithms trained on decade-old data to deny cancer treatments that are now standard of care, stamping proven therapies "experimental" because a cheaper, older option still technically exists. He walks through the quiet arithmetic behind it: the models fit the average patient, so the algorithm rejects the roughly one in three whose disease doesn't match the pattern. In the case he opens with, a retired OB-GYN upheld the denial of an oncology treatment, which he compares to taking your car to a burger counter for a repair.The denials are legal, they're profitable, and almost no one with the power to stop them has a reason to.We Also CoverFor patients: A "not medically necessary" or "experimental" denial is often a first move, not a final verdict. An appeal that cites current oncology guidelines (the kind published by bodies like the NCCN) is the standard way to fight it.For clinicians: The denial rationale frequently hinges on outdated, cost-driven criteria rather than current evidence, Attaching guideline support to the initial request, not just the appeal, gives the "experimental" label nowhere to land.System-level: The whole model rests on a 1970s federal law that shields employer health plans from meaningful oversight, so denials can generate cash flow with little accountability

A neurosurgeon kills seven patients. The state medical board lets him quietly resign — no license revocation, no public record, a clean slate to operate in the next state. That is not a failure of oversight. That is oversight working exactly as some boards intend it to.In this episode, Dr. A tears through four real cases where state medical boards — the bodies legally entrusted to protect patients — instead protected themselves. A dental board weaponized cease-and-desist letters against competitors. A telehealth giant had to sue its own regulatory body to keep serving patients. And an orthopedic surgeon in the Southwest had his license targeted on the basis of a complaint that included a fabricated patient — a man who never filed a grievance and said his doctor had saved his life. The boards in these cases shared one trait: they were controlled by active practitioners with something to lose. When the regulator and the competitor are the same person, the patient is the last thing on the agenda. These aren't edge cases. The Supreme Court has already ruled on one of them.We also cover:For patients: If a medical board disciplines your doctor, the public record may not tell you why — and the case against them may rest on a complaint you never made, or a consultant who never spoke to you.For clinicians: Board consultants reviewing your case are often unnamed, unexamined, and operating solely from the written record — knowing this changes how you document everything, starting now.System-level: When active market participants control the regulatory body that governs their own competition, antitrust law — not medical ethics boards — may be the only lever that works.

You trained fifteen years to become a doctor. Nobody trained you to spot the person who spends the next decade quietly draining everything you built.This week Dr. A talks about hard lessons from his own years fighting a former partner he can only name by a pseudonym while the case sits in court. His warning is for physician entrepreneurs: smart, fresh out of training, sitting on a real idea, and nearly defenseless against the kind of "investor" who shows up offering to be a savior. He lays out the exact playbook — the manufactured rescue, the grab for control of the money, the conflicted vendor referrals — then sets it beside a celebrity entrepreneur's recent suit alleging her own managers looted her fortune. The pattern is identical.The money, he says, you can earn back. The years you burn fighting for it, you can't.We Also Cover:For physician entrepreneurs: Run a "progressive dating period" before anyone gets equity or control.For clinicians eyeing a deal: When a prospective partner pushes a specific vendor, ask straight out whether they own a piece of it or take a profit share — a referral that pays them twice is a conflict, not a favor.System-level: These setups run on blurring family and fiduciary — once a "partner" has cast himself as your mentor, big brother, or savior, questioning the books starts to feel like betraying a relative. That's the design.

Hospitals are quietly firing their best doctors — not for malpractice, not for complaints, but for costing 8 to 12 percent more than a cheaper alternative. When a 20-year oncologist with 100% patient satisfaction and zero blemishes gets cut to protect a margin, something has broken beyond repair.In this episode, Dr. A pulls back the curtain on a pattern accelerating across specialties — radiology, oncology, anesthesia — where exceptional clinicians are being replaced not by better ones, but by cheaper ones. The engine behind it is private equity and insurance-owned hospital systems operating on a simple mandate: generate margin, cut cost, and move on.If the numbers work out — 70% margin, 4% more deaths — hospital leadership has already told you which one they will choose. We also cover:For clinicians: Doctors who resist should focus their attention on the CFO, because is the only person in the building who speaks the language that can save your contract.For patients: Radiology is the canary in the coal mine. AI-driven replacement is not a future threat.System-level: Insurance companies now own hospitals, clinics, and imaging centers, and they are running physician staffing decisions like an Excel algorithm.

Three out of four physicians in America no longer own their own practice. The entity that now controls their decisions, their staffing, their billing — is not a doctor. It is a private equity firm with a five-year exit strategy and no obligation to the patient sitting in the exam room.In this solo episode, Dr. A breaks down what he calls the darkest deal in modern medicine: the private equity acquisition of physician practices. Between 2013 and 2020, nearly a thousand practices were absorbed by PE-backed consolidators — each time triggering the same playbook: cut staff, replace doctors with mid-levels, crank patient volume, code aggressively, and sell before the whole thing collapses. Dr. A traces how a model built for returns on IT companies and fast food chains has been force-fitted onto cardiology offices and ophthalmology suites — and why scaling a body is not the same as scaling a balance sheet.We also cover:For patients: Knowing the ownership structure of your practice is the first step to protecting yourself.For clinicians: Before burning out and selling to a PE-backed consolidator, physicians should know that AI-powered practice management tools can now handle a significant portion of administrative workload.System-level: The doctrine of corporate practice of medicine exists in many states but is almost never enforced

Fourteen years of training doesn’t prepare you for this.One bad business decision can nearly end a medical career.In this season-one finale, Dr. A tells a true story from early in his career—what happened when a newly trained physician stepped into entrepreneurship without business training, formal safeguards, or verification. Fresh out of fellowship, at the dawn of digital medicine, he partnered with close friends to build a new kind of radiology practice. The idea was right. The timing was right. The execution was not.This isn’t about blame. It’s about pattern recognition—and stopping history from repeating itself. If you’re trained to save lives, who teaches you to protect your own?We Also CoverFor patients: Why physician burnout and system pressure often start long before you ever meet your doctorFor clinicians: The hidden risk of entering business without verification, incentives, or guardrailsSystem-level: How medical training structurally omits business literacy—and why that gap keeps costing careers

Physicians no longer control many of the decisions that shape patient care—and that loss didn’t happen overnight. According to Dr. A, it took decades of fragmented choices, missed chances to act together, and quiet acceptance of outside control.In this episode of They Did What, Dr. A delivers a blunt reckoning with the medical profession itself. He traces how professional culture, competition, and failure to unify created openings for insurers, corporate owners, and legal frameworks to move into clinical decision-making. The result: defensive medicine, productivity quotas, and care shaped as much by billing codes as by patient need.This is not about blaming individual clinicians. It’s about how shared behaviors—embracing commercialization, tolerating fragmentation, and avoiding collective advocacy—slowly weakened professional authority. We Also CoverFor patients: Why your doctor may be constrained even when they agree with your care planFor clinicians: How professional fragmentation reduced leverage with payers and institutionsSystem-level: How cultural norms inside medicine enabled long-term corporatization

Nearly 1 in 4 healthcare workers report being bullied by a supervising physician, according to a major 2019 review. And inside some large medical centers, that culture isn’t improving—it’s spreading. That is the minefield Dr. A walks us through today.In this episode, Dr. A breaks down how toxic hierarchies, unchecked “star performer” protection, and hostile peer dynamics create a workplace that can quietly harm both physicians and the patients who rely on them. From radiologists treated as “second-class,” to trainees pushed to silence, to real cases where speaking up triggered retaliation, we map how a broken culture ripples from the reading room to the exam room.We translate the research, separate fact from opinion, and show how structural issues—weak leadership training, tenure shields, burnout, and rigid hierarchies—fuel the problem. If this culture drives physicians out, who is left to care for patients?What happens to patient safety when the caregivers themselves are under constant fire?We Also CoverFor patients: What toxic culture can look like from the outside and how it may impact communication or wait times.For clinicians: Early warning signs of unhealthy hierarchies and how to protect your professional boundaries.System-level: Why leadership training (not just clinical skill) is essential to stop the cycle.

When one attorney can threaten a major transplant center with a multimillion-dollar payout, the whole system feels shaky. And when a federal jury convicts that attorney of attempted extortion, it exposes a pressure point most patients never see coming.In this episode, Dr. A walks listeners through a real 2024 federal case involving a plaintiff-side medical malpractice lawyer. An example of how rare but extreme misconduct can distort a system meant to protect patients. Dr. A also breaks down why litigation data lives forever, how this shapes physician behavior, and why only a minority of states use patient-compensation funds to stabilize payouts.When a bad outcome happens, who’s accountable and who decides what counts as malpractice?We Also CoverFor patients: What a verified negligent act actually means—and how to vet an attorney.For clinicians: Why documentation is your strongest protection in non-negligent bad-outcome cases.System takeaway: How patient-compensation funds can reduce unnecessary lawsuits—and why they’re rare.